IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Conversely, both CML and PV stem cells have recently been demonstrated to be targeted by interferon alpha (IFNa) [12–14], but it is not well understood which pathways are responsible for the IFNa response in both diseases.